Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

NCT: NCT05620095 · RECRUITING

NCT IDNCT05620095
StatusRECRUITING
Start Date2020-12-01
Completion2026-11-01

Brief Summary

This study is a multicenter observational study designed to evaluate the the effectiveness and safety of drug-coated balloon (DCB) angioplasty for below the knee arterial lesions in patients critical with Limb Threatening Ischemia (CLTI).

Frequently Asked Questions

What is Durg Coated Balloon Angioplasty in Infrapopliteal Lesions?

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions is a clinical trial registered under NCT05620095. Current status: RECRUITING.

What is the status of NCT05620095?

The current status of NCT05620095 (Durg Coated Balloon Angioplasty in Infrapopliteal Lesions) is: RECRUITING.

When did Durg Coated Balloon Angioplasty in Infrapopliteal Lesions start?

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions started on 2020-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑